| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.16 | 0.009 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.069 | 0.2 |